The new article highlights certain specific matters to be addressed in all the applications for a medical device license in order to ensure the authority is provided with all the information needed to assess the safety and effectiveness of the product subject to review.

Health Canada Guidance on Investigation of Reported Medical Device Problems: Risk Evaluation and Control

Health Canada, the country’s regulating authority in the sphere of healthcare products, has published detailed guidelines dedicated to the application process to be followed by interested parties applying for a medical device license. The document describes in detail the relevant regulatory requirements and also provides additional clarifications and recommendations to be taken into consideration by medical device manufacturers and other parties involved in order to ensure compliance thereto. However, it is also important to mention that the authority reserves the right to make changes to the guidelines and recommendations provided therein, should such changes be reasonably necessary to reflect corresponding amendments to the underlying regulation.

Medical Device License Application Types

First of all, the document provides additional clarifications regarding the medical device license application types set forth under the existing legal framework. According to the document they include: 

  • Single Medical Device Applications: These applications refer to individual devices distinguished by a unique name and packaging. Unlike medical device groups or families, single devices can range from acupuncture needles to larynx prostheses, each sold in potentially different package sizes but under a singular identity.
  • Medical Device Family: This category covers medical devices produced by the same manufacturer that may vary only in non-critical aspects such as shape, color, or size. Despite these variations, all devices within a family share identical design processes and intended uses. Examples would be various medical tools such as insulin syringes and vascular access grafts.
  • Medical Device Group: Referring to devices sold as a unit, such as procedure packs or trays, this category emphasizes the composite nature of these products. Each group, which might include denture repair kits or disposable circumcision trays, is unified under a single name, enhancing the efficiency of medical procedures.
  • Medical Device Group Family: This category represents an extension of the medical device group, accommodating collections that share a generic name but differ in the composition and number of products. An example would be a contact lens care kit.
  • System: Systems are comprised of components or parts, initially designed to work together to achieve a device’s intended functions. This category addresses the complex interdependencies within devices like hip prostheses or ultrasonic imaging systems, each sold under a singular name to signify its integrated functionality.
  • Test Kit: Specifically tailored for in vitro diagnostic activities, test kits encompass reagents or articles designed for conducting precise tests. This category highlights the specialized nature of diagnostic devices and their critical role in medical analysis and treatment.
FDA on tissue heating cooling devices (specific aspects)

Place of Use and Drug Containment

According to the guidance, to ensure completeness of the application, an interested party should also provide information about the intended place of use of the device.

In particular, the application necessitates a clear indication of where the device will be utilized, guiding the regulatory body in understanding its context of use and assessing the relevant risks associated to it.

This step ensures that devices are appropriately classified and evaluated based on their intended environments.

The authority also mentions that applicants must provide exhaustive details, including brand names, active ingredients, and manufacturing information for devices incorporating drugs or substances, whether pharmaceutical, biological, or natural health products.

Additional Aspects

The document further highlights certain specific points to be taken into consideration by the parties interested in placing their products on the Canadian market including, among other things, the following ones:

  • Historical Device Authorization: Applications must disclose any previous authorizations under investigational testing or special access provisions, providing a transparent background that aids in the current evaluation process.
  • Device Identification Requirements: Ensuring accurate device identification is vital, involving detailed listings of devices, components, and their identifiers. The respective documentation facilitates regulatory oversight and ensures that each device’s composition and materials are thoroughly understood and compliant with the safety standards they are subject to.
  • Interdependent Device Compatibility: The authority further emphasizes the importance of the compatibility and collective functionality of devices intended to be used together. This requirement ensures device efficacy and patient safety, providing for a rigorous review of how devices interact within a medical setting.
  • Compliance with Recognized Standards: Applicants must list the standards adhered to in the manufacturing process, providing a declaration of conformity or equivalent evidence. This section emphasizes the importance of consistent quality and safety benchmarks in device production to ensure compliance with the applicable regulatory requirements.
  • Priority Review Eligibility: Following the applicable legislation, devices that promise significant advancements in treating or diagnosing severe conditions may qualify for priority review, a pathway designed to expedite the availability of groundbreaking medical solutions.
    This pathway facilitates the availability of medical devices to address unmet clinical needs.

Conclusion

The presented guidance issued by Health Canada provides a comprehensive overview of the general content of an application for a medical device license required for the product to be allowed for marketing and use in the country.

The document highlights the key points to be taken into consideration by medical device manufacturers to ensure completeness of the application and thus facilitate and streamline the review process.

How Can RegDesk Help?

RegDesk is a holistic Regulatory Information Management System that provides medical device and pharma companies with regulatory intelligence for over 120 markets worldwide. It can help you prepare and publish global applications, manage standards, run change assessments, and obtain real-time alerts on regulatory changes through a centralized platform. Our clients also have access to our network of over 4000 compliance experts worldwide to obtain verification on critical questions. Global expansion has never been this simple.

RegDesk is recognized as a Regulatory Intelligence Representative Vendor! Learn more by reading the 2024 Gartner® Market Guide for Regulatory Intelligence Solutions.

Get the report